Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy

SIMPLE SUMMARY: Chemotherapy with immune checkpoint inhibitors is the new standard of care for first-line systemic therapy in extensive small-cell lung cancer. The identification of biomarkers for patients that are likely or not likely to respond to such therapy is critical. We aimed at determining...

Descripción completa

Detalles Bibliográficos
Autores principales: Grambow-Velilla, Julia, Seban, Romain-David, Chouahnia, Kader, Assié, Jean-Baptiste, Champion, Laurence, Girard, Nicolas, Bonardel, Gerald, Matton, Lise, Soussan, Michael, Chouaïd, Christos, Duchemann, Boris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136504/
https://www.ncbi.nlm.nih.gov/pubmed/37190152
http://dx.doi.org/10.3390/cancers15082223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136504/
https://www.ncbi.nlm.nih.gov/pubmed/37190152
http://dx.doi.org/10.3390/cancers15082223

Ejemplares similares